Artiva Biotherapeutics Chief Tech Operations Officer Horan Christopher sold 10,366 shares at $11.16 per share on September 3, 2026. For investors, the transaction identifies both the disclosed sale price and the 283,084 shares Horan Christopher continued to own after the transaction, clarifying the reported post-sale ownership position.

Key Highlights

  • Horan Christopher serves as Artiva Biotherapeutics’ Chief Tech Operations Officer.
  • According to the Form 4, Horan Christopher sold 10,366 Artiva Biotherapeutics shares.
  • Horan Christopher owned 283,084 Artiva Biotherapeutics shares after the transaction.

Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) saw Chief Tech Operations Officer Horan Christopher sell 10,366 shares at $11.16 per share. The transaction was dated September 3, 2026.

Artiva Biotherapeutics Transaction Details

The transaction carried code S and involved Artiva Biotherapeutics shares. The reported price was $11.16 per share, with 10,366 shares sold.

Post-Transaction Ownership

Horan Christopher owned 283,084 shares after the transaction. The stated holding represents the ownership position recorded following the sale.